Immune Interception Approaches for Individuals at Risk for Pancreatic Cancer

Meeting Date and Time
Virtual via Zoom
Elizabeth M. Jaffee, M.D., FAACR, FACP, FAAAS
DCP Immunology Interest Group Seminar Series
Major Program
Cancer Immunoprevention Network
PREVENT Cancer Preclinical Drug Development Program
Research Group
Chemopreventive Agent Development
Gastrointestinal and Other Cancers

Date Posted

Please join the NCI Division of Cancer Prevention Immunology Interest Group (DCP IIG) seminar series talk focused on cancer prevention, interception, and immuno-oncology.


Elizabeth M. Jaffee, M.D., FAACR, FACP, FAAAS

Elizabeth M. Jaffee, M.D., FAACR, FACP, FAAAS
The Dana and Albert “Cubby” Broccoli Professor of Oncology
Deputy Director, Sidney Kimmel Cancer Center
Johns Hopkins Medicine

Dr. Jaffee is an internationally recognized expert in cancer immunology and pancreatic cancer. She is Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Co-Director of the Skip Viragh Pancreatic Cancer Center and Associate Director of the Bloomberg Kimmel Institute for Cancer Immunotherapy. Her research focus is on developing novel immunotherapies for the treatment and prevention of pancreatic cancer. Her recent work has focused on developing novel biomarker driven immunotherapy clinical trials to dissect the complex inflammatory signals within the tumor microenvironment. Through collaborations with computational biologists, her team has identified a number of immune suppressive signals that regulate pancreatic cancer development and progression.

Dr. Jaffee is a Past President of AACR. She has served on a number of committees at the National Cancer Institute, including the co-chair of the Biden Moonshot Blue Ribbon Panel which identified high impact research priorities for the NCI. She currently serves as Chief Medical Advisor to the Lustgarten Foundation for Pancreatic Cancer Research. She is the inaugural director of the Convergence Institute for Integrating Technologies and Computational Sciences at Johns Hopkins. Dr. Jaffee is a member of the National Academy of Medicine, a Fellow of the American College of Physicians, a Fellow of American Association for the Advancement of Science, a Fellow of the SITC Academy of Immuno-Oncology and a Fellow of the AACR Academy. Most recently, she was appointed chair of President Biden’s Cancer Panel.

Dr. Jaffee is passionate about supporting and mentoring women and underrepresented individuals in science and medicine. She has received a number of awards for her efforts including the Assistant Dean’s Award for Women Mentorship, and the Dean’s Mentoring Award.